---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-292093"
form_type: "8-K"
ticker: "CUE"
cik: "0001645460"
company_name: "Cue Biopharma, Inc."
filed_at: "2025-11-24T23:59:59+00:00"
generated_at: "2026-05-16T17:19:23.869549+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# Cue Biopharma posts updated corporate presentation on website; no specific new facts disclosed

## Summary
- Company made an updated corporate presentation available on its website on November 24, 2025.
- The presentation was furnished as Exhibit 99.1 to the 8-K filing.
- No financial results, material transactions, or forward-looking guidance were included in the filing text.

## SEC filing metadata
- accession: 0001193125-25-292093
- form_type: 8-K
- ticker: CUE
- cik: 0001645460
- company_name: Cue Biopharma, Inc.
- filed_at: 2025-11-24T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1645460/000119312525292093/0001193125-25-292093-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1645460/000119312525292093/cue-20251124.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-292093
- JSON: https://secwatch.observer/filing/0001193125-25-292093.json
- Plain text: https://secwatch.observer/filing/0001193125-25-292093.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.